LncRNA MNX1-AS1 Contributes to Lung Adenocarcinoma Progression by Targeting the MiR-34a/SIRT1 Axis

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2022 Aug 12

PMID 35958481

Authors

Gaofeng Liu

Yong Zhang

Xiaozhen Zhang

Yan Liu

Yanbin Xu

Sujuan Cui

Gang Li

Jianjun Wang

Affiliations

Soon will be listed here.

Abstract

LncRNA MNX1-AS1 is known to be involved in progression of several tumor types. However, few studies have investigated the molecular mechanism of MNX1-AS1 in lung adenocarcinoma (LAC). To explore the function of MNX1-AS1 in the pathogenesis of LAC, qRT-PCR was performed to show MNX1-AS1 expression. MNX1-AS1 expression in LAC cells was suppressed by siRNA to detect the biologic behavior. The relationships among miR-34a, MNX1-AS1 and SIRT1 were confirmed by pull-down and dual-luciferase reporter assay. Whether MNX1-AS1 was involved in LAC by targeting miR-34a/SIRT1 axis was verified. MNX1-AS1 was up-regulated in LAC, and over-expression of MNX1-AS1 was significantly associated with lymph node metastasis and poor prognosis. In A549 and H1299 cells, cell proliferation, migration, and invasion were suppressed, the cell cycle was regulated, as well as apoptosis was increased after silencing MNX1-AS1. Mechanistically, MNX1-AS1 served as a ceRNA of miR-34a to down-regulate miR-34a expression. SIRT1 is targeted by miR-34a and its expression is regulated by MNX1-AS1 and miR-34a. Up-regulation of SIRT1 salvaged the effect of silencing MNX1-AS1 on A549 and H1299 cells, to some extent. These results showed that MNX1-AS1 contributes to LAC progression by targeting the miR-34a/SIRT1 axis.

Citing Articles

Downregulation of lncRNA MNX1-AS1 promotes the ferroptosis and apoptosis of non-small cell lung cancer.

Chi X, Feng L, Wang L, Yu S, Wei M, Zhang Q Int J Med Sci. 2025; 22(5):1052-1063.

PMID: 40027180 PMC: 11866536. DOI: 10.7150/ijms.97790.

Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks.

Braga E, Fridman M, Burdennyy A, Loginov V, Dmitriev A, Pronina I Int J Mol Sci. 2023; 24(17).

PMID: 37686426 PMC: 10487663. DOI: 10.3390/ijms241713617.

References

Gao Y, Xu Y, Wang J, Yang X, Wen L, Feng J . lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443. Oncol Res. 2018; 27(3):341-347. PMC: 7848264. DOI: 10.3727/096504018X15228909735079. View

Duan K, Ge Y, Zhang X, Wu S, Feng J, Chen S . miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression. Oncol Lett. 2016; 10(5):3223-3227. PMC: 4665267. DOI: 10.3892/ol.2015.3645. View

Ji D, Wang Y, Sun B, Yang J, Luo X . Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis. Biochem Biophys Res Commun. 2019; 513(3):669-674. DOI: 10.1016/j.bbrc.2019.04.012. View

Liu H, Han L, Liu Z, Gao N . Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway. J Cell Physiol. 2019; 234(8):13843-13850. DOI: 10.1002/jcp.28064. View

Qin J, Ning H, Zhou Y, Hu Y, Yang L, Huang R . LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma. Biomed Pharmacother. 2018; 99:363-368. DOI: 10.1016/j.biopha.2018.01.037. View

Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

Zhang J, Xu T, Liu L, Zhang W, Zhao C, Li S . LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer. PLoS Comput Biol. 2020; 16(4):e1007851. PMC: 7200020. DOI: 10.1371/journal.pcbi.1007851. View

Fang C, Qiu S, Sun F, Li W, Wang Z, Yue B . Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA. Cancer Lett. 2017; 410:50-62. DOI: 10.1016/j.canlet.2017.09.012. View

Lu Q, Rui Z, Guo Z, Xie W, Shan S, Ren T . LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression. J Cell Mol Med. 2017; 22(3):1527-1537. PMC: 5824415. DOI: 10.1111/jcmm.13420. View

10.

Cheng Y, Pan Y, Pan Y, Wang O . MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer. Cancer Manag Res. 2019; 11:803-812. PMC: 6340505. DOI: 10.2147/CMAR.S188007. View

11.

Knight S, Crosbie P, Balata H, Chudziak J, Hussell T, Dive C . Progress and prospects of early detection in lung cancer. Open Biol. 2017; 7(9). PMC: 5627048. DOI: 10.1098/rsob.170070. View

12.

DAngelo D, Mussnich P, Sepe R, Raia M, Del Vecchio L, Cappabianca P . RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins. J Mol Med (Berl). 2019; 97(7):1019-1032. DOI: 10.1007/s00109-019-01789-7. View

13.

Li A, Zhang H . Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2017; 21(24):5618-5623. DOI: 10.26355/eurrev_201712_14003. View

14.

Cao L, Jin H, Zheng Y, Mao Y, Fu Z, Li X . DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway. Cancer Sci. 2018; 110(3):913-925. PMC: 6398927. DOI: 10.1111/cas.13921. View

15.

Kang M, Shi J, Li B, Luo M, Xu S, Liu X . LncRNA DGCR5 regulates the non-small cell lung cancer cell growth, migration, and invasion through regulating miR-211-5p/EPHB6 axis. Biofactors. 2019; 45(5):788-794. DOI: 10.1002/biof.1539. View

16.

Zhang W, Huang L, Lu X, Wang K, Ning X, Liu Z . Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Bosn J Basic Med Sci. 2019; 19(2):164-171. PMC: 6535387. DOI: 10.17305/bjbms.2019.3713. View

17.

Zhou T, Gao Y . Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. World J Surg Oncol. 2016; 14(1):8. PMC: 4709863. DOI: 10.1186/s12957-015-0757-5. View

18.

Jiang W, Wang Z, Chen G, Jia Y . Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resection. Thorac Cancer. 2016; 7(3):316-22. PMC: 4846620. DOI: 10.1111/1759-7714.12330. View

19.

Ma W, Xiao G, Mao J, Lu Y, Song B, Wang L . Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness. Oncotarget. 2015; 6(12):10432-44. PMC: 4496365. DOI: 10.18632/oncotarget.3394. View

20.

Liu G, Guo X, Zhang Y, Liu Y, Li D, Tang G . Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer. Onco Targets Ther. 2019; 12:3129-3138. PMC: 6497912. DOI: 10.2147/OTT.S198014. View